| Open Document File Size: 64,66 KBShare Result on Facebook
Facility American College of Rheumatology / / MedicalCondition aseptic meningitis / anaphylactic reaction / allergic reaction / tumor necrosis factor receptor / disease / polyarticular-course juvenile rheumatoid arthritis / inflammatory processes / arthritis / ENBREL Polyarticular-Course Juvenile Rheumatoid Arthritis / Carcinogenesis / rheumatoid arthritis / chronic / RA disease / tumor necrosis factor / juvenile rheumatoid arthritis / normal inflammatory and immune responses / hypersensitivity / infection / inflammation / murine collagen-induced arthritis / depression / Infections / varicella / sepsis / / MedicalTreatment immunization / Immunosuppression / Immunizations / vaccination / / Organization American College of Rheumatology / Pharmacokinetics After administration / / Position Physician global assessment / physician / General / CLINICAL PHARMACOLOGY General / / Product SC / ENBREL / sulfasalazine / MTX tablets / Bacteriostatic Water for Injection / prednisone / azathioprine / mannitol / / Technology alpha / Pharmacokinetics / antibodies / recombinant DNA technology / /
SocialTag |
ENBREL® (etanercept) DESCRIPTION ENBREL (etanercept) is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to th